Literature DB >> 15921850

Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression.

Ratchada Cressey1, Sarunya Pimpa, Waragorn Tontrong, Onusa Watananupong, Nirush Leartprasertsuke.   

Abstract

Elevated cyclooxygenase-2 (COX-2) expression has been observed in various types of cancer. Induction of COX-2 expression has been reported to increase invasiveness and angiogenesis of tumours. While COX-2 overexpression has been repeatedly proven to promote tumor growth, little is known about what initiates its induction. There has been evidence to suggest that COX-2 expression is normally suppressed by wild-type p53 but not mutant p53, suggesting that loss of p53 function may result in the induction of COX-2 expression. Loss of p53 function is not only caused by gene mutation, but also through the overexpression of its negative regulator, so called human double minute 2 (hdm2). The aim of this study was to examine the correlation between COX-2 overexpression, p53 accumulation and HDM2 overexpression, as indications of p53 anomalies, and their relationship to clinicopathologic features of colorectal adenocarcinoma. Tumor tissues and the adjacent normal mucosa were obtained from 73 colorectal cancer patients who underwent curative resection at Maharaj Nakorn Chiang Mai Hospital. Protein levels of COX-2, p53 and HDM2 were determined by Western blot analysis. No normal colorectal tissues possessed detectable levels of COX-2, p53 or HDM2. In contrast, 38.3% (28 cases), 54.8% (40 cases) and 8.2% (6 cases) of tumour tissues were found to express COX-2, p53 and HDM2, respectively. Interestingly, there was a significantly positive relationship between COX-2 overexpression and p53 accumulation and/or HDM2 overexpression (P=0.007). Higher COX-2 overexpression was observed in p53-accumulated or HDM2 overexpressed-tumours (22/43 cases, 51.1%) in comparison to tumours with no evidence of p53 and HDM2 alterations (6/30 cases, 20%). The results obtained from this study indicate that overexpression of COX-2 is frequently associated with p53 protein accumulation and HDM2 overexpression, therefore the COX-2 overexpression observed in colorectal cancer cells may be partly due to the dysfunction of p53. Although mutation of p53 has been previously reported to be associated with COX-2 induction, to our knowledge, this is the first study to show the relationship between HDM2 overexpression and COX-2 overexpression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15921850     DOI: 10.1016/j.canlet.2005.03.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Expression profile of NF-κB regulated genes in sporadic colorectal cancer patients.

Authors:  Betsy Annel González-Quezada; Uriel Francisco Santana-Bejarano; Alfredo Corona-Rivera; Helia Judith Pimentel-Gutiérrez; Rocío Silva-Cruz; Citlalli Ortega-De-la-Torre; Ramón Franco-Topete; Karina Franco-Topete; Manuel Willebaldo Centeno-Flores; Víctor Manuel Maciel-Gutiérrez; Jorge Román Corona-Rivera; Juan Armendáriz-Borunda; Lucina Bobadilla-Morales
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

Review 2.  Inflammation and cancer: how friendly is the relationship for cancer patients?

Authors:  Bharat B Aggarwal; Prashasnika Gehlot
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

3.  COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status.

Authors:  Annika Gustafsson Asting; Helena Carén; Marianne Andersson; Christina Lönnroth; Kristina Lagerstedt; Kent Lundholm
Journal:  BMC Cancer       Date:  2011-06-13       Impact factor: 4.430

4.  Expression of cyclooxygenase-2 and its relationship to p53 accumulation in colorectal cancers.

Authors:  Sung-Chul Lim; Tae-Beum Lee; Cheol-Hee Choi; So-Yeon Ryu; Kyung-Jong Kim; Young-Don Min
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

5.  Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature.

Authors:  Ling Peng; Yun Zhou; Yina Wang; Haibo Mou; Qiong Zhao
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

6.  The impact of COX-2 on invasion of osteosarcoma cell and its mechanism of regulation.

Authors:  Xing Wu; Ming Cai; Fang Ji; Lie-Ming Lou
Journal:  Cancer Cell Int       Date:  2014-03-25       Impact factor: 5.722

Review 7.  Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?

Authors:  Si-Min Qi; Gang Cheng; Xiang-Dong Cheng; Zhiyuan Xu; Beihua Xu; Wei-Dong Zhang; Jiang-Jiang Qin
Journal:  Front Cell Dev Biol       Date:  2020-04-02

8.  Differential Expression of HER2 and SKP2 in Benign and Malignant Colorectal Lesions.

Authors:  Mona Moussa; Afkar Badawy; Noha Helal; Fatma Hegab; Magdy Youssef; Tarek Aboushousha; Lubna Al Faruok; Dalal Elwy
Journal:  Asian Pac J Cancer Prev       Date:  2020-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.